John K. Simmons

1.4k total citations
37 papers, 771 citations indexed

About

John K. Simmons is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, John K. Simmons has authored 37 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in John K. Simmons's work include Cancer Genomics and Diagnostics (8 papers), Religious Education and Schools (3 papers) and Renal cell carcinoma treatment (3 papers). John K. Simmons is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Religious Education and Schools (3 papers) and Renal cell carcinoma treatment (3 papers). John K. Simmons collaborates with scholars based in United States, Netherlands and Spain. John K. Simmons's co-authors include Beverly A. Mock, Gary W. Dickson, Shuling Zhang, Aleksandra M. Michalowski, Lindsey B. Saunders, John S. Schneekloth, David Calabrese, B. Voight, Derek Elsworth and Joy Gary and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

John K. Simmons

35 papers receiving 747 citations

Peers

Countries citing papers authored by John K. Simmons

Since Specialization

Citations

This map shows the geographic impact of John K. Simmons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John K. Simmons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John K. Simmons more than expected).

Fields of papers citing papers by John K. Simmons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John K. Simmons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John K. Simmons. The network helps show where John K. Simmons may publish in the future.

Co-authorship network of co-authors of John K. Simmons

This figure shows the co-authorship network connecting the top 25 collaborators of John K. Simmons. A scholar is included among the top collaborators of John K. Simmons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John K. Simmons. John K. Simmons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Petagraph: A large-scale unifying knowledge graph framework for integrating biomolecular and biomedical data 2024 ·Scientific Data ·Benjamin Stear, Taha Mohseni Ahooyi, John K. Simmons, (unknown), (unknown), (unknown), (unknown), (unknown), Tiffany J. Callahan, (unknown), Jonathan C. Silverstein, Deanne Taylor	3
2	Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells 2022 ·Clinical Cancer Research ·Iris van ’t Erve, Jamie E. Medina, Alessandro Leal, (unknown), Jillian Phallen, Vilmos Adleff, Elaine J. Chiao, Adith S. Arun, Karen Bolhuis, John K. Simmons, (unknown), (unknown), Mark Sausen, Samuel V. Angiuoli, Robert B. Scharpf, Cornelis J. A. Punt, Gerrit A. Meijer, Victor E. Velculescu, Remond J.A. Fijneman	22
3	Hypomorphic mTOR Downregulates CDK6 and Delays Thymic Pre-T LBL Tumorigenesis 2020 ·Molecular Cancer Therapeutics ·Joy Gary, John K. Simmons, Jinfei Xu, Shuling Zhang, (unknown), Nicholas Watson, (unknown), Ke Zhang, Alexander L. Kovalchuk, Aleksandra M. Michalowski, Jin‐Qiu Chen, Tuddow Thaiwong, Matti Kiupel, Snehal Gaikwad, (unknown), Richard J. Simpson, Wendy Dubois, Joseph R. Testa, Beverly A. Mock	8
4	521TiP Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer according the trials within cohorts design: The MEDOCC-CrEATE trial 2020 ·Annals of Oncology ·(unknown), (unknown), (unknown), (unknown), Jillian Phallen, Mark Sausen, John K. Simmons, Veerle M.H. Coupé, (unknown), (unknown), Helena M. Verkooijen, Linda J.W. Bosch, Daan van den Broek, Gerrit A. Meijer, Victor E. Velculescu, Remond J.A. Fijneman, Geraldine R. Vink, Miriam Koopman	5
5	Mouse tumor susceptibility genes identify drug combinations for multiple myeloma 2020 ·Journal of Cancer Metastasis and Treatment ·Shuling Zhang, Wendy Dubois, Ke Zhang, John K. Simmons, V. Keith Hughitt, (unknown), Snehal Gaikwad, (unknown), Beverly A. Mock	3
6	Geriatric oncology health services research: Cancer and Aging Research Group infrastructure core 2019 ·Journal of Geriatric Oncology ·Melisa L. Wong, Stuart M. Lichtman, Gary R. Morrow, John K. Simmons, (unknown), Cary P. Gross, Jennifer L. Lund, Lisa M. Lowenstein, Louise C. Walter, Cara L. McDermott, Supriya G. Mohile, Harvey Jay Cohen	7
7	Characterization of tumor mutational burden (TMB), PD-L1, and DNA repair genes to assess correlation with immune checkpoint inhibitors (ICIs) response in metastatic renal cell carcinoma (mRCC). 2019 ·Journal of Clinical Oncology ·Matthew Labriola, Jason Zhu, Rajan T. Gupta, Shannon J. McCall, Jennifer Jackson, James R. White, (unknown), (unknown), Peter D. Simone, (unknown), (unknown), John K. Simmons, Daniel J. George, Tian Zhang	4
8	Identification of MET gene amplifications using next-generation sequencing in non-small cell lung cancer patients 2019 ·Annals of Oncology ·Sergi Clavé, Marta Salido, Pedro Rocha, (unknown), (unknown), (unknown), (unknown), Gustavo C. Cerqueira, Donna Nichol, John K. Simmons, Álvaro Taus, Lara Pijuán, Beatríz Bellosillo, Edurne Arriola	4
9	Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex 2018 ·Nature Communications ·David Calabrese, Xiang Chen, (unknown), Snehal Gaikwad, (unknown), William M. Hewitt, Stephanie Alden, Thomas A. Hilimire, Fahu He, Aleksandra M. Michalowski, John K. Simmons, Lindsey B. Saunders, Shuling Zhang, (unknown), Kylie J. Walters, Beverly A. Mock, John S. Schneekloth	137
10	Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation 2017 ·Molecular Cancer Therapeutics ·John K. Simmons, Aleksandra M. Michalowski, (unknown), Wendy Dubois, Jyoti D. Patel, Ke Zhang, Joy Gary, Shuling Zhang, Snehal Gaikwad, (unknown), Nicholas Watson, (unknown), Jin‐Qiu Chen, W. Michael Kuehl, Maxwell P. Lee, Adriana Zingone, Ola Landgren, Peter Ordentlich, Jing Huang, Beverly A. Mock	27
11	mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination Screening 2016 ·Scientific Reports ·Lu Chen, Kelli M. Wilson, Ian S. Goldlust, Bryan T. Mott, Richard T. Eastman, Mindy I. Davis, Xiaohu Zhang, Crystal McKnight, Carleen Klumpp‐Thomas, Paul Shinn, John K. Simmons, (unknown), Sam Michael, Craig J. Thomas, Marc Ferrer, Rajarshi Guha	8
12	Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activity 2014 ·Cancer Letters ·(unknown), Konrad Hüppi, Sirisha Chakka, Kristen Gehlhaus, Wendy Dubois, Jyoti D. Patel, Jinqiu Chen, Mark Mackiewicz, Tamara L. Jones, Jason J. Pitt, Scott E. Martin, Paul K. Goldsmith, John K. Simmons, Beverly A. Mock, Natasha J. Caplen	22
13	B Cell–Specific Deficiencies in mTOR Limit Humoral Immune Responses 2013 ·The Journal of Immunology ·Shuling Zhang, Margaret Pruitt, (unknown), (unknown), Ke Zhang, Rushi S. Patel, Shelley Hoover, R. Mark Simpson, John K. Simmons, Joy Gary, Clifford M. Snapper, Rafael Casellas, Beverly A. Mock	72
14	TORC1 and class I HDAC inhibitors synergize to suppress mature B cell neoplasms 2013 ·Molecular Oncology ·John K. Simmons, Jyoti D. Patel, Aleksandra M. Michalowski, Shuling Zhang, Bih-Rong Wei, (unknown), (unknown), (unknown), W. Michael Kuehl, Richard J. Simpson, Adriana Zingone, Ola Landgren, Beverly A. Mock	24
15	Mouse genetics 2011: meeting report 2012 ·Mammalian Genome ·John K. Simmons, (unknown), Thomas R. Geiger, Karlyne M. Reilly, Kent W. Hunter, Beverly A. Mock	2
16	Loss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesis 2010 ·Oncogene ·Kathleen DeCicco-Skinner, (unknown), John K. Simmons, Patricia Lepage, Jonathan S. Wiest	31
17	Vanishing Boundaries: When Teaching About Religion Becomes Spiritual Guidance in the Classroom 2006 ·Teaching Theology & Religion ·John K. Simmons	11
18	The gardens of William Morris 1998 ·(unknown), John K. Simmons	2
19	Teaching about Religions in State History Courses: The Religious Contours of California and Illinois 1993 ·The Social Studies ·John K. Simmons	0
20	The 150-Hour Requirement in Florida 1991 ·Journal of accountancy online/Journal of accountancy ·(unknown), John K. Simmons	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact